Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020204117 - PHARMACEUTICAL COMPOSITION HAVING FAVORABLE STABILITY

Publication Number WO/2020/204117
Publication Date 08.10.2020
International Application No. PCT/JP2020/015129
International Filing Date 02.04.2020
IPC
A61P 5/18 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
5Drugs for disorders of the endocrine system
18of the parathyroid hormones
A61P 43/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
43Drugs for specific purposes, not provided for in groups A61P1/-A61P41/108
A61K 9/08 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
08Solutions
A61K 47/02 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
02Inorganic compounds
A61K 47/10 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
08containing oxygen
10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols ; Poloxamers; PEG/POE alkyl ethers
A61K 47/12 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
08containing oxygen
12Carboxylic acids; Salts or anhydrides thereof
Applicants
  • EAファーマ株式会社 EA PHARMA CO., LTD. [JP]/[JP]
Inventors
  • 牧田 良道 MAKITA Yoshimichi
  • 片岡 大輔 KATAOKA Daisuke
  • 久山 和雄 KUYAMA Kazuo
  • 浅野 謙司 ASANO Kenji
  • 芝崎 僚太郎 SHIBASAKI Ryotaro
  • 山本 愛希子 YAMAMOTO Akiko
  • 我妻 広貴 WAGATSUMA Hirotaka
  • 鶴田 敦 TSURUTA Atsushi
  • 鷹橋 俊之 TAKAHASHI Toshiyuki
Agents
  • 小林 浩 KOBAYASHI Hiroshi
  • 星川 亮 HOSHIKAWA Ryo
  • 鈴木 康仁 SUZUKI Yasuhito
Priority Data
2019-07116803.04.2019JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) PHARMACEUTICAL COMPOSITION HAVING FAVORABLE STABILITY
(FR) COMPOSITION PHARMACEUTIQUE PRÉSENTANT UNE STABILITÉ AMÉLIORÉE
(JA) 安定性の良好な医薬組成物
Abstract
(EN)
Provided is a pharmaceutical composition which contains 3-{[(2S)-2-amino-2-carboxyethyl]carbamoylamino}-5-chloro-4-methylbenzene sulfonic acid, a pharmaceutically acceptable salt thereof, or a solvate thereof, has a pH of at most 8.0, and has favorable pharmaceutical composition stability.
(FR)
L'invention concerne une composition pharmaceutique qui contient de l'acide 3-{[(2S)-2-amino-2-carboxyéthyl]carbamoylamino}-5-chloro-4-méthylbenzène sulfonique, un sel pharmaceutiquement acceptable de celui-ci, ou un solvate de celui-ci, qui présente un pH de 8,0 maximum, et une stabilité de composition pharmaceutique favorable.
(JA)
ここでは、3-{[(2S)-2-アミノ-2-カルボキシエチル]カルバモイルアミノ}-5-クロロ-4-メチルベンゼンスルホン酸、その製薬学的に許容される塩又はそれらの溶媒和物を含み、8.0以下のpHを有する医薬組成物安定性の良好な医薬組成物が提供される。
Latest bibliographic data on file with the International Bureau